Skip to main content

New Products: Pathogenica's HAI BioDetection Kit; Ariosa's Harmony Prenatal Test

Premium

Pathogenica has launched its HAI BioDetection Kit to detect hospital acquired infections using its DxSeq technology platform.

The kit uses next-gen sequencing to screen for 12 different pathogens and 15 resistance gene families in a single assay. Up to 12 patient samples can be tested at once, enabling dozens of samples to be tested in one day, according to the company.

The kit is marketed as research use only and is compatible with any sequencing platform. As part of its launch, the company has partnered with Life Technologies Japan to distribute the kit in Japan on the Ion Torrent platform.


Through a partnership with Laboratory Corporation of America, Ariosa Diagnostics has launched its Harmony Prenatal Test at select locations and will launch it more broadly in June. The noninvasive sequencing-based fetal trisomy test is available for women at least 10 weeks into their pregnancy with a single fetus conceived without the use of an egg donor. It is available for all women, regardless of risk of trisomy, the company said.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.